Should hyperlipoproteinemia be treated in patients with coronary artery disease?
D000293:Adolescent; D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000150:complications; D001835:Body Weight; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003327:Coronary Disease / Q000150:complications*; D004035:Diet Therapy; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000145:classification / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D008074:Lipoproteins / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D012116:Resins, Plant; D014280:Triglycerides / Q000097:blood
D008074:Lipoproteins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D009539:Nicotinic Acids; D012116:Resins, Plant; D014280:Triglycerides; D002792:Cholestyramine Resin; D002994:Clofibrate